Sanofi signs letter of intent with Tricog Health EP News Bureau Sep 8, 2026 Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup that…
Dupixent (dupilumab) gets DCGI approval to treat moderate-to-severe atopic dermatitis EP News Bureau Jul 11, 2023 Dupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement
